基于假体乳房再造中自体脂肪移植时机:基于系统评价与Meta分析的最佳实践
该系统评价与Meta分析检索PubMed/MEDLINE(2010-2022年)共纳入6项研究216例患者,比较假体乳房再造第二期与第三期脂肪移植的BREAST-Q满意度,结果显示两组满意度评分无显著差异(p=0.178),第二期脂肪移植未增加后续修整手术需求。
要点
- 第二期与第三期脂肪移植的BREAST-Q满意度评分无显著差异(p=0.178)。
- 第二期脂肪移植未增加后续修整手术需求。
- 结合既往研究,第二期脂肪移植以更少手术次数提供等效甚至更优的临床与生活质量结局。
核心结论
- 结合既往工作,该Meta分析提示第二期脂肪移植以更少手术次数为扩张器/假体乳房再造患者提供等效甚至更优的临床与生活质量结局。
研究设计与样本
- 系统评价与Meta分析,检索PubMed/MEDLINE数据库(2010-2022年),纳入6项研究共216例患者。
- BREAST-Q评分采用随机效应模型及DerSimonian-Laird法合并,事后敏感性分析采用Hartung-Knapp-Sidik-Jonkman法,低计数结局采用Haldane-Anscombe校正,分析遵循PRISMA指南。
主要发现
- 合并随机效应模型显示,第二期与第三期脂肪移植患者的BREAST-Q满意度结局评分无显著变化(p=0.178),敏感性分析结果稳健。
- 现有数据的合并分析显示,与第三期脂肪移植相比,第二期脂肪移植未增加后续修整手术需求。
临床怎么用
- 作者认为,第二期脂肪移植以更少手术次数提供等效甚至更优的临床与生活质量结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fat grafting is commonly undertaken as a third-stage procedure in patients with staged implant-based breast reconstruction (IBR). However, fat grafting performed during second-stage expander/implant exchange provides faster results without an additional procedure and associated risks (Patel et al., 2020). We previously demonstrated that fat grafting during second-stage expander/implant exchange did not increase clinical complications (Patel et al., 2020). As a corollary, this study investigates patients' satisfaction with second- versus third-stage fat grafting to help establish a set of best practices for the timing of fat grafting in such patients. METHODS: A review of PubMed/MEDLINE databases (2010-2022) was performed to identify articles investigating the quality of life in patients undergoing second- or third-stage fat grafting after IBR. BREAST-Q scores were pooled using random-effects modeling and the DerSimonian-Laird method. Post-hoc sensitivity analyses were completed using the Hartung-Knapp-Sidik-Jonkman method. The Haldane-Anscombe correction was used for outcomes with low counts. All study analyses adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. RESULTS: Six studies (216 patients) were included. Pooled random-effects modeling demonstrated no significant changes in BREAST-Q satisfaction with outcome scores when comparing patients who received second- versus third-stage fat grafting (p = 0.178) with results robust to sensitivity analyses. In addition, pooled analyses of the available data demonstrated that second-stage fat grafting did not increase downstream revision surgery needs compared to third-stage fat grafting. CONCLUSIONS: In combination with our prior work, this meta-analysis suggests that second-stage fat grafting provides not only equivalent but improved clinical and quality of life outcomes with fewer procedures in patients undergoing expander/IBR.
引用
- Maheta B, Yesantharao PS, Thawanyarat K, et al. Timing of autologous fat grafting in implant-based breast reconstruction: Best practices based on systematic review and meta-analysis. J Plast Reconstr Aesthet Surg. 2023. PMID: 37797375. doi:10.1016/j.bjps.2023.09.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。